CLINICAL TRIAL: NEURODEVELOPMENTAL / NEUROLOGICAL STUDY OF INFANTS/CHILDREN WITH

临床试验：患有以下疾病的婴儿/儿童的神经发育/神经学研究

• 批准号: 7950780
• 负责人: Sharon A Nachman
• 金额: $ 4.14万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7950780
• 关键词: AIDS clinical trial group; Blood; Blood Cells; Caring; Child; Clinical; Clinical Research; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Infant; Infection; Institution; Knowledge; Laboratories; Medical; Medicine; Mothers; Neurologic; Pharmaceutical Preparations; Pregnant Women; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Virus; Work; fighting

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. ACTG 219 The purpose of this study is to collect and study clinical and laboratory information about you and your medical care in order to increase our knowledge of the best care for HIV-infected pregnant women and their children. The study will look at how good different medications are in lowering the chance that a baby born to an HIV-infected mother will get HIV.The study will also look at how different medicines work to lower the amount of virus in the blood or increase the blood cells that help the body fight infection.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 中心，不一定是研究者的机构。 ACTG 219 本研究的目的是收集和研究有关您和您的医疗护理的临床和实验室信息，以增加我们对感染 HIV 的孕妇及其子女的最佳护理的了解。该研究将探讨不同的药物在降低感染艾滋病毒的母亲所生的婴儿感染艾滋病毒的机会方面有何效果。该研究还将研究不同的药物如何降低血液中的病毒数量或增加血液中的病毒数量。帮助身体抵抗感染的血细胞。